532296:BOM
Glenmark Pharmaceuticals Ltd
₹2,244.50
arrow_downward
-0.99%(-22.50) 1D
Oct 14, 3:52:37 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹2,282.30
High
₹2,285.00
Low
₹2,244.50
Mkt. cap
633.49B
Avg. vol.
19.50K
Volume
5.55K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.24
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,282.30
High
₹2,285.00
Low
₹2,244.50
Mkt. cap
633.49B
Avg. vol.
19.50K
Volume
5.55K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.24
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
The Economic Times
·
2 days ago
Glenmark Pharmaceuticals - Positive Breakout: These 11 stocks cross above their 200 DMAs
Business Standard
·
2 days ago
3 bullish stocks to track: Glenmark Pharma, Karur Vysya Bank and Go Digit
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd